Breast cancer subtype and baseline characteristics from diabetic breast cancer patients are not different from nondiabetics

Breast Journal

Volumn 20, Issue 4, 2014, Pages 434-436

  Campos Gomez, Saúl ^a,b   Valero, Vicente ^c   Flores Arredondo, Jose Humberto ^a   Isassi Chapa, Adolfo ^a   Rangel Rodríguez, Ignacio ^a   Hortobagyi, Gabriel N ^c   Gonzalez Angulo, Ana Maria ^c  

^a ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

breast cancer; breast cancer subtypes; type 2 diabetes

Indexed keywords

ADIPOCYTE; ADVANCED CANCER; ANGIOGENESIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CELL PROLIFERATION; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; HUMAN; LETTER; LYMPH VESSEL METASTASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTIAL MASTECTOMY; PATIENT CARE; SIGNAL TRANSDUCTION; TUMOR CELL; BREAST NEOPLASMS; FEMALE; METABOLISM; PATHOLOGY;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84903716809     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12294     Document Type: Letter

References (14)

1. Mokdad AH, Ford ES, Bowman BA, et al,. Diabetes trends in the U.S.: 1990-1998. Diabetes care 2000; 23: 1278-83.
2. Harris MI,. Impaired glucose tolerance in the U.S. population. Diabetes Care 1989; 12: 464-74.
3. Li Y, Xu W, Liao Z, et al,. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 2004; 27: 2597-602.
4. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S,. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871-7.
5. Kuriki K, Hirose K, Tajima K,. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev 2007; 16: 83-9.
6. Czyzyk A, Szczepanik Z,. Diabetes mellitus and cancer. Eur J Intern Med 2000; 11: 245-52.
7. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B,. Diabetes mellitus and breast cancer. Lancet Oncol 2005; 6: 103-11.
8. Bianchini F, Kaaks R, Vainio H,. Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3: 565-74.
9. Papa V, Belfiore A,. Insulin receptors in breast cancer: biological and clinical role. J Endocrinol Invest 1996; 19: 324-33.
10. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH,. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 2009; 27: 2170-6.
11. Beckman TJ, Cuddihy RM, Scheitel SM, Naessens JM, Killian JM, Pankratz VS,. Screening mammogram utilization in women with diabetes. Diabetes Care 2001; 24: 2049-53.
12. Kerbel RS,. Tumor angiogenesis. N Engl J Med 2008; 358: 2039-49.
13. Fain JN, Madan AK,. Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes. Metabolism 2005; 54: 220-6.
14. Bermont L, Lamielle F, Lorchel F, et al,. Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells. J Clin Endocrinol Metabol 2001; 86: 363-8.